Novo Nordisk Announces $4 Billion Expansion to Meet Rising Ozempic Demand in the US
Novo Nordisk's market worth exceeds that of Denmark as a whole, and its shares have increased ...
Search Result for ' Novo Nordisk'
No Result
Pfizer Acquires Metsera for $10 Billion, Enters Obesity Drug Market
After receiving the offer, Pfizer enters the highly lucrative obesity drug market, although Metsera’s products are ...
Can Spain Sustain its Position in Pharma with China and US Closing In?
Spain is currently leading Europe in clinical trials, with its hospitals, research facilities, and biotech in ...
Ozempic Price Hike Drives Spike in Counterfeit Drug Cases
The United States Customs and Border (CBP) seized 11 shipments of counterfeit Ozempic at Cincinnati airport, ...
Ozempic’s Success is Breaking Denmark’s EconomyÂ
Ozempic's unparalleled weight-loss effects swiftly captured global attention In 2022, Novo Nordisk, a Danish pharmaceutical company, ...
Chinese Biotech Startups Hit Profit Milestone in 2025
Chinese biotech companies Innovent, BeOne, and Akeso have earned billions of yuan from licensing drug candidates ...
Trump’s Order on US Drugs Might Increase Global Drug Prices
When the US compared its prices with other countries, it was two to four times more ...
The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.
